Correlation Between ChemoMetec and MapsPeople

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ChemoMetec and MapsPeople at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoMetec and MapsPeople into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChemoMetec AS and MapsPeople AS, you can compare the effects of market volatilities on ChemoMetec and MapsPeople and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoMetec with a short position of MapsPeople. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoMetec and MapsPeople.

Diversification Opportunities for ChemoMetec and MapsPeople

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ChemoMetec and MapsPeople is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding ChemoMetec AS and MapsPeople AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MapsPeople AS and ChemoMetec is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoMetec AS are associated (or correlated) with MapsPeople. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MapsPeople AS has no effect on the direction of ChemoMetec i.e., ChemoMetec and MapsPeople go up and down completely randomly.

Pair Corralation between ChemoMetec and MapsPeople

Assuming the 90 days trading horizon ChemoMetec AS is expected to generate 0.31 times more return on investment than MapsPeople. However, ChemoMetec AS is 3.24 times less risky than MapsPeople. It trades about 0.34 of its potential returns per unit of risk. MapsPeople AS is currently generating about -0.01 per unit of risk. If you would invest  48,200  in ChemoMetec AS on November 27, 2024 and sell it today you would earn a total of  11,100  from holding ChemoMetec AS or generate 23.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ChemoMetec AS  vs.  MapsPeople AS

 Performance 
       Timeline  
ChemoMetec AS 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ChemoMetec AS are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, ChemoMetec exhibited solid returns over the last few months and may actually be approaching a breakup point.
MapsPeople AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days MapsPeople AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

ChemoMetec and MapsPeople Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ChemoMetec and MapsPeople

The main advantage of trading using opposite ChemoMetec and MapsPeople positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoMetec position performs unexpectedly, MapsPeople can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MapsPeople will offset losses from the drop in MapsPeople's long position.
The idea behind ChemoMetec AS and MapsPeople AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes